Non-Palindromic C∧C∧P Platinum and Palladium Pincer Complexes Showing Intense Phosphorescence via Direct Spin-Forbidden S0 → T1 Excitation.

The synthesis of C∧C∧P pre-ligands based on a dicyclohexylphosphine-substituted biphenyl framework is reported. The pre-ligands form the respective non-palindromic pincer complexes of PtII and PdII via double oxidative addition and subsequent comproportionation or C-H activation. The complexes of PtII as well as PdII emit similar green phosphorescence efficiently in the solid state, the former also in solution albeit with less intensity. The most fascinating photophysical feature, however, is a direct singlet-triplet (S0 → T1) excitation of this phosphorescence in the spectral window between the emission and the major singlet-singlet UV absorption. The S0 → T1 excitation spectra show a rich vibronic pattern, which is especially pronounced for the solid samples at cryogenic temperatures. The molar extinction of the lowest-energy singlet-triplet absorption band of the homologous Pt and Pd complexes as well as that of the Pt complex with a different (NHC) ancillary ligand were determined in tetrahydrofuran solutions. Quantum efficiencies of triplet formation (by intersystem crossing) via the "standard" excitation pathway S0 → Sn → T1 were determined for the Pt complexes and found to be different in dependence of the ancillary ligand.

Synthesis and Characterization of Telmisartan-Derived Cell Death Modulators to Circumvent Imatinib Resistance in Chronic Myeloid Leukemia.

New strategies to eradicate cancer stem cells in chronic myeloid leukemia (CML) include a combination of imatinib with peroxisome proliferator-activated receptor gamma (PPARγ) ligands. Recently, we identified the partial PPARγ agonist telmisartan as effective sensitizer of resistant K562 CML cells to imatinib treatment. Here, the importance of the heterocyclic core on the cell death-modulating effects of the telmisartan-derived lead 4'-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid (3 b) was investigated. Inspired by the pharmacodynamics of HYL-6d and the selective PPARγ ligand VSP-51, the benzimidazole was replaced by a carbazole or an indole core. The results indicate no correlation between PPARγ activation and sensitization of resistant CML cells to imatinib. The 2-COOH derivatives of the carbazoles or indoles achieved low activity at PPARγ, while the benzimidazoles showed 60-100 % activation. Among the 2-CO2 CH3 derivatives, only the ester of the lead (2 b) slightly activated PPARγ. Sensitizing effects were further observed for this non-cytotoxic 2 b (80 % cell death), and to a lesser extent for the lead 3 b or the 5-Br-substituted ester of the benzimidazoles (5 b).